FDA Sets April 22, 2027 Action Date for Two Merck HIV Drug Applications

The FDA accepted two supplemental New Drug Applications for IDVYNSO, with an April 22, 2027 target action date for both. Merck will present HIV portfolio and pipeline data at HIV Glasgow 2026, Nov. 8–11.